DC661
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 408008

CAS#: 1872387-43-3

Description: DC661 is a potent palmitoyl-protein thioesterase 1 (PPT1) inhibitor. DC661 inhibits autophagy. DC661 is capable of deacidifying the lysosome and inhibiting autophagy significantly better than hydroxychloroquine (HCQ).


Price and Availability

Size
Price

10mg
USD 150
100mg
USD 850
1g
USD 3250
Size
Price

25mg
USD 250
200mg
USD 1450
2g
USD 5850
Size
Price

50mg
USD 450
500mg
USD 2250

DC661, purity > 98%, is in stock. The same day shipping out after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 408008
Name: DC661
CAS#: 1872387-43-3
Chemical Formula: C31H39Cl2N5
Exact Mass: 551.2583
Molecular Weight: 552.588
Elemental Analysis: C, 67.38; H, 7.11; Cl, 12.83; N, 12.67


Synonym: DC661; DC-661; DC 661;

IUPAC/Chemical Name: N1-(7-chloroquinolin-4-yl)-N6-(6-((7-chloroquinolin-4-yl)amino)hexyl)-N6-methylhexane-1,6-diamine

InChi Key: VJKCWFZTSDXOBS-UHFFFAOYSA-N

InChi Code: InChI=1S/C31H39Cl2N5/c1-38(20-8-4-2-6-16-34-28-14-18-36-30-22-24(32)10-12-26(28)30)21-9-5-3-7-17-35-29-15-19-37-31-23-25(33)11-13-27(29)31/h10-15,18-19,22-23H,2-9,16-17,20-21H2,1H3,(H,34,36)(H,35,37)

SMILES Code: CN(CCCCCCNC1=CC=NC2=CC(Cl)=CC=C12)CCCCCCNC3=CC=NC4=CC(Cl)=CC=C34


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:

Safety Data Sheet (MSDS):

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.90.01


References

1: Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A,
McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E,
Martorella A, Alicea GM, Lee JJ, Schuchter LM, Xu X, Herlyn M, Marmorstein R,
Gimotty PA, Speicher DW, Winkler JD, Amaravadi RK. PPT1 Promotes Tumor Growth and
Is the Molecular Target of Chloroquine Derivatives in Cancer. Cancer Discov. 2019
Feb;9(2):220-229. doi: 10.1158/2159-8290.CD-18-0706. Epub 2018 Nov 15. PubMed
PMID: 30442709; PubMed Central PMCID: PMC6368875.